financetom
Business
financetom
/
Business
/
Douglas Elliman Q3 revenue dips, Adjusted EBITDA improves
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Douglas Elliman Q3 revenue dips, Adjusted EBITDA improves
Nov 4, 2025 3:53 AM

Overview

* Douglas Elliman Q3 2025 revenue fell slightly from Q3 2024, with $262.8 mln reported

* Adjusted EBITDA for Q3 2025 improved to $2.7 mln from $2.3 mln in Q3 2024

Outlook

* Douglas Elliman ( DOUG ) expects a $75 mln after-tax gain in Q4 from property management sale

* Company focuses on international expansion and AI investments for future growth

* Douglas Elliman ( DOUG ) sees improved market conditions in 2026 and beyond

Result Drivers

* INTERNATIONAL EXPANSION - Co expanded into France and Monaco, contributing to growth initiatives

* AI INVESTMENTS - Investments in AI aimed at enhancing agent and client experience

* FINANCIAL POSITION - Redemption of convertible notes improved financial flexibility

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 $262.80

Revenue mln

Q3 $200,000

Adjusted

Net

Income

Q3 Net -$24.70

Income mln

Q3 $2.70

Adjusted mln

EBITDA

Q3 -$10.70

Operatin mln

g Income

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Humana forecasts annual profit lower than estimates
Humana forecasts annual profit lower than estimates
Feb 11, 2025
Feb 11 (Reuters) - Humana forecast annual profit slightly below Wall Street estimates on Tuesday, signaling that costs from its government-backed plans for older Americans would remain elevated for the rest of the year. The company sees 2025 adjusted profit per share of about $16.25 compared to analysts' estimate of $16.71 per share, according to data compiled by LSEG. ...
Alarm.com Acquires Majority Stake in CHeKT
Alarm.com Acquires Majority Stake in CHeKT
Feb 11, 2025
06:33 AM EST, 02/11/2025 (MT Newswires) -- Alarm.com Holdings ( ALRM ) said Tuesday that it has acquired a majority stake in CHeKT, a cloud platform for remote video monitoring services. Financial terms of the transaction were not disclosed. CHeKT will continue to operate independently. Alarm.com's ( ALRM ) video solution and the OpenEye enterprise video solution will be fully...
Paramount Global's Acquisition by Ellison Family Clears EU Regulatory Hurdle
Paramount Global's Acquisition by Ellison Family Clears EU Regulatory Hurdle
Feb 11, 2025
06:38 AM EST, 02/11/2025 (MT Newswires) -- Paramount Global's ( PARAA ) acquisition by Lawrence J. Ellison, David Ellison, and RedBird Capital Partners has been approved by the European Commission, the European Union's antitrust regulator said Tuesday. The commission said it has approved the acquisition of joint control of Paramount-controlled movie theater chain National Amusements by the Ellison family and...
Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics
Novartis Strikes Up to $3.1 Billion Deal to Buy Anthos Therapeutics
Feb 11, 2025
06:32 AM EST, 02/11/2025 (MT Newswires) -- Novartis ( NVS ) on Tuesday agreed to acquire biopharmaceutical firm Anthos Therapeutics in a deal worth up to $3.1 billion, as the Swiss pharmaceutical giant looks to boost its cardiovascular portfolio. Anthos was launched by Novartis ( NVS ) and Blackstone (BX) unit Blackstone Life Sciences in 2019. The firm has exclusive...
Copyright 2023-2026 - www.financetom.com All Rights Reserved